Altered generation of induced regulatory T cells in the FVB.mdr1a-/- mouse model of colitis

S M Tanner1, E M Staley, R G Lorenz

  • 1Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Mucosal Immunology
|August 10, 2012
PubMed

Insights

P-glycoprotein (P-gp) deficiency in mice reduces regulatory T cells (Tregs) crucial for gut health. This occurs because P-gp deficiency impairs the development of induced Tregs, potentially impacting inflammatory bowel disease.

Area of Science:

  • Immunology
  • Gastroenterology

Background:

  • The FVB.mdr1a(-/-) mouse model lacks P-glycoprotein (P-gp), a key efflux pump.
  • P-gp deficiency and MDR1 gene variations are linked to human ulcerative colitis.
  • Regulatory T cells (Tregs) play a vital role in maintaining intestinal immune homeostasis.

Purpose of the Study:

  • To investigate the impact of P-gp deficiency on Treg populations in the gut.
  • To elucidate the mechanisms underlying altered Treg levels in P-gp deficient mice.
  • To explore the potential role of P-gp in inflammatory bowel disease pathogenesis.

Main Methods:

  • Comparison of Treg populations in wild-type and P-gp deficient (FVB.mdr1a(-/-)) mice.
  • Assessment of Treg apoptosis, trafficking, and plasticity.
  • In vitro studies of induced Treg (iTreg) development using TGF-β.
  • Adoptive transfer experiments into immunodeficient recipients.

Main Results:

  • P-gp deficient mice exhibited significantly lower levels of Foxp3(+) Tregs in the intestinal lamina propria.
  • The reduction in Tregs was not attributed to increased apoptosis, altered trafficking, or plasticity.
  • P-gp deficiency impaired the in vitro development of iTregs from naive T cells upon TGF-β stimulation.
  • TGF-β stimulation in P-gp deficient cells resulted in a shift towards IL-17(+)CD4(+) T cells instead of Tregs.
  • Adoptive transfer confirmed impaired iTreg development in P-gp deficient recipients.

Conclusions:

  • P-gp deficiency restricts the development of induced Tregs, leading to decreased Treg numbers in the intestine.
  • This impaired iTreg development represents a novel mechanism potentially contributing to inflammatory bowel disease.
  • Further investigation into this mechanism in human patients with MDR1 polymorphisms is warranted.

Related Concept Videos